online). We interpreted the reduction in HIF-1 ␣ protein levels by CAN as a result of the known ability of tedanolide macrolides to inhibit protein synthesis. However, we also noticed that HIF-1 ␤ and ␤ -actin, proteins with a longer half-life than HIF-1 ␣ , were not similarly affected, even when cells were exposed to as much as 100 nM CAN for as long as 18 hours ( Supplementary Figure 2 , available online); thus, the reduction in HIF-1 ␣ protein levels was likely to be attributable to the short half-life of the protein. Based on these preliminary results, we decided to further investigate whether CAN, like other tedanolide macrolides, inhibited protein synthesis overall and whether that mechanism and/or others might be responsible for CAN's potent cytotoxic activity in the NCI 60-cell-line screen.
Protein translation is often increased by genetic alterations in human cancers and by dysregulation of signal transduction pathways that contribute to cancer progression ( 10 , 11 ) . Translation initiation is the main step in the regulation of protein synthesis, and several factors regulate this critical process ( 12 ) . Eukaryotic translation initiation factor-2 (eIF2) mediates binding of initiator transfer RNAs to the small ribosomal unit and is a key regulator of translation initiation ( 13 ) . Phosphorylation of the ␣ subunit of eIF2 is a well-documented mechanism for the inhibition of protein synthesis ( 14 ) . Among other kinases, both double-stranded RNAdependent protein kinase (PKR) and PKR-like endoplasmic reticulum kinase (PERK) can phosphorylate and inhibit eIF2 ␣ to inhibit most translation during conditions of cellular stress. The eukaryotic initiation factor 4E (eIF4E) binding proteins (4E-BPs), which sequester eIF4E from eIF4G and control recognition of mRNA via the 5 ′ cap, are also important regulators of translation initiation ( 15 -17 ) . The kinase mammalian target of rapamycin (mTOR) can activate 5 ′ cap -dependent translation by phosphorylating 4E-BP1 and preventing it from binding and inhibiting eIF4E ( 18 ) .
Apoptosis, or programmed cell death, is also frequently dysregulated in cancer cells ( 19 ) . In the extrinsic pathway of apoptosis, extracellular ligands activate death receptors such as tumor necrosis factor receptor (TNFR) and Fas at the cell surface, resulting in the activation of the cysteine protease caspase 8. In the intrinsic pathway of apoptosis, apoptotic stimuli such as radiation, toxins, viral infections, hypoxia, or withdrawal of growth factors result in changes at the mitochondrial membrane that cause release of proteins, including cytochrome c, and subsequent activation of caspase 9 via Apaf-1. Both caspases 8 and 9 activate the downstream "executioner" caspase 3, which causes endonuclease activation, leading to chromatin condensation; cytoskeletal reorganization, leading to formation of apoptotic cell bodies; and externalization of phosphatidylserine to the outer plasma membrane, allowing detection of apoptotic cells using annexin V.
Stress conditions, when they are unresolved by measures that are meant to protect cells, such as translational inhibition, can lead to apoptosis by additional pathways that are incompletely understood. For example, in the presence of unresolved endoplasmic reticulum (ER) stress due to conditions such as hypoxia, several pathways can lead to apoptosis ( 20 , 21 ) . In one such pathway, the ER protein IRE1 recruits c-jun NH 2 -terminal inhibitory kinase and TNFR-associated factor-2, which leads to the activation of apoptosis-signaling kinase 1, and JNK. In another pathway, caspase 12 is activated at the ER membrane; it then activates caspase 9 to activate caspase 3 in an apoptotic pathway that does not involve mitochondria or death receptors. In yet another pathway, the ER protein PERK, while inactivating eIF2 ␣ and thereby in hibiting most translation, promotes translation of the transcription factor ATF4, which induces the proapoptotic transcription factor C/EBP-homologous protein (CHOP). Alternatively, in virus-infected cells or in response to lipopolysaccharide, serum deprivation, or TNF-␣ treatment, among other stressors, the interferon-inducible double-stranded RNA -regulated protein kinase PKR can mediate the induction of apoptosis ( 22 , 23 ) . PKRmediated apoptosis appears to often proceed through phosphorylation of eIF2 ␣ , which can elevate ATF4 and CHOP protein levels. However, PKR-mediated apoptosis may also involve other pathways, including the nuclear factor-кB pathway, which can be proapoptotic under certain conditions, and/or the FADD/caspase 8 and Apaf-1/caspase 9 pathways.
In this study, we examined the effects of CAN on both global protein synthesis, as a measure of translation, and on apoptosis in human cancer cells. We then looked at CAN-mediated apoptosis in the presence of inhibitors of caspases 3, 8, 9, and 12 to determine which pathways might be necessary for CAN-mediated cytotoxicity. Next, we looked at the p38 and JNK pathways and at eIF2 ␣ phosphorylation to determine whether they might mediate the translational and/or apoptotic activities of CAN. The effects of CAN on the expression or activation of various proteins modulated by ER stress, including ATF4, CHOP, and PERK, as well as its effect on PKR activity, were examined. A nonphosphorylatable
CONTEXT AND CAVEATS

Prior knowledge
Candidaspongiolide (CAN), a tedanolide macrolide, was discovered to be the active compound in an extract from marine sponges that killed glioma and melanoma cells in the NCI 60-cell-line screen. The mechanism of cytotoxicity was not known, although related compounds have been reported to inhibit protein synthesis.
Study design
Cell and molecular assays were done to examine the effects of CAN on protein synthesis and apoptosis pathways in U251 glioma cells and HCT116 colorectal cancer cells, as well as in normal cells.
Contribution
CAN inhibited protein synthesis and induced apoptosis in the tested cancer cell lines by a mechanism that included activation of caspase 12 and protein kinase PKR and inhibitory phosphorylation of eukaryotic initiation factor-2 (eIF2)-␣ . CAN also appeared able to inhibit protein synthesis by additional pathway(s). In the normal cell lines, CAN inhibited protein synthesis but did not activate the PKR/eIF2 ␣ pathway or apoptosis.
Implications
The in vitro activity of CAN raises the possibility that it will have antitumor activity against tumors in vivo.
Limitations
Further testing of CAN's safety and efficacy in treating tumors in mouse models will be necessary before its usefulness in humans can be evaluated.
From the Editors
Downloaded from https://academic.oup.com/jnci/article-abstract/100/17/1233/905718 by guest on 28 January 2019 mutant of eIF2 ␣ and inhibitors of PKR were then introduced into U251 cells to determine whether these could block CAN-mediated apoptosis. Last, we examined whether CAN was able to inhibit translation and induce apoptosis in normal cells.
Materials and Methods
Cell Lines and Culture Conditions
Cell lines were obtained from the Developmental Therapeutics Program of the National Cancer Institute. U251 human glioma cells were cultured in RPMI 1640 medium supplemented with 5% heatinactivated fetal bovine serum (FCS), 50 IU/mL penicillin, 50 µ g/mL streptomycin, and 2 mM glutamine. MCF7 human breast adenocarcinoma (used only in Supplementary Figure 2 ) and HCT116 human colorectal carcinoma cells were cultured in RPMI 1640 medium supplemented with 10% FCS. AG06858 and AG068103, normal human fibroblast cell lines, were cultured in Dulbecco's minimal essential medium with 10% FCS. Cells were normally grown at 37°C in 5% CO 2 and ambient oxygen (normoxic) conditions. For those experiments requiring hypoxia, hypoxic conditions were achieved in an InVivo 2 400 hypoxic workstation (Ruskinn Technologies, Cincinnati, OH) set to deliver a 1% oxygen atmosphere in the presence of 5% CO 2 at 37°C. Exponentially growing HCT116, U251, and MCF7 cells were seeded at a density of 10 6 cells per 100-mm dish and incubated for 24 hours in complete medium. The next day, cells were exposed for 6 or 18 hours to normoxia or hypoxia in the presence or absence of different doses of CAN.
Reagents
CAN was isolated at the Developmental Therapeutics Program, NCI-Frederick, by a process that included two-dimensional nuclear magnetic resonance and mass spectrographic analysis ( 2 ) . In our studies we used the purified compound. CAN was dissolved in dimethyl sulfoxide and stored in aliquots at -20°C. CAN was routinely added to cells 30 minutes before incubation under hypoxia or before the addition of other agents, unless otherwise indicated.
The translational inhibitor bis -cycloheximide oxaldihydrazone (CHX, 40 µ g/mL for 2 hours), protesome inhibitor carbobenzoxyleucyl-leucyl-leucinal-ZLLal (MG132, 10 µ M), PKR inhibitor 2-aminopurine (2-AP) (5 mM), p38 kinase inhibitor SB202190 (10 µ M), and JNK inhibitor SP600125 (10 µ M) were obtained from Sigma Chemical Company (St Louis, MO). All inhibitors were routinely added to the cells 30 minutes before the addition of CAN. For apoptosis assays, HCT116 cells were treated with 50 nM CAN for 48 hours in the absence or presence of 10 µ M Ac-DEVD-fmk (caspase 3 inhibitor), 10 µ M Ac-ZIETD-fmk (caspase 8 inhibitor), 10 µ M Ac-ZLEHD-fmk (caspase 9 inhibitor), 10 µ M Ac-ZATAD-fmk (caspase 12 inhibitor), or 10 µ M Z-VAD-fmk (pan-caspase inhibitor) before annexin V and propidium iodide (PI) staining analysis by fl ow cytometry (see below). Specifi c inhibitors of caspase 3, caspase 8, and caspase 9 and the total caspase inhibitor Z-VAD-fmk were obtained from Calbiochem (San Diego, CA). The specifi c inhibitor of caspase 12 was obtained from Biovision (Mountain View, CA). Cells treated with thapsigargin (2 µ M) and tunicamycin (20 µ M) were used as positive controls for caspase 12 activation. In contrast, camptothecin (1 µ M), which did not cause activation of caspase 12, was used as negative control. Thapsgargin, tunicamycin, and camptothecin were all obtained from Sigma.
Clonogenic Cell Survival Assay
For the clonogenic assay, cells that had been grown to confluence in six-well plates were incubated with different concentrations of CAN for 6 hours. Immediately after treatment with CAN, cells were plated in 60-mm culture dishes at a density of 500 cells per dish in RPMI medium containing 10% FCS and then kept in a humidified incubator at 37°C and 5% CO 2 for 2 weeks. Colonies were fixed and stained with 1% crystal violet (Sigma) in 10% methanol and counted. Percentage of colonies arising from surviving treated cells was calculated relative to colonies arising from untreated control cells.
Generation of U251 Cells Expressing Dominant-Negative eIF2 ␣
A nonphosphorylatable mutant form of eIF2 ␣ (S51A), cloned at the Hin dIII site of plasmid pRc/CMV (Invitrogen, Carlsbad, CA), was a kind gift of C. Koumenis ( 24 ) . Exponentially growing U251 cells were seeded (2 × 10 5 cells per well in six-well plates) and incubated for 24 hours in complete medium. The next day, cells were transfected with 1 µ g of plasmid pCMV-neo or pCMV-eIF2 ␣ -S51A using Effectene (Qiagen, Hilden, Germany). After 48 hours, cells were detached with trypsin, counted, and plated in RPMI complete medium on 100-mm dishes at three different cell densities: 10 000, 1000, and 100 cells per plate. After another 24 hours, 800 µ g/mL G418 (Geneticin, Invitrogen) was added to the medium, and the cells were incubated in the presence of the drug (replaced with fresh medium every 4 days) for a total of 2 weeks. Individual G418-resistant clones containing fewer than 200 cells per clone were isolated and expanded. The pooled clones were routinely cultured in the presence of G418 (100 µ g/mL) to minimize the expansion of revertant cells.
Small-Interfering RNA Transfection
Small-interfering RNAs (siRNAs) that silence the expression of protein kinase RNA-activated (PKR siRNA, No. 11185) or endoplasmic reticulum (ER) stress -activated protein kinase (PERK siRNA, No. 18102) were obtained from Ambion (Austin, TX), and control (nonsilencing) siRNA was obtained from Qiagen. U251 cells were transfected with 100 nM siRNA. Trans fection was performed using oligofectamine reagent (Invitrogen) according to the manufacturer's instructions. Following transfection, cells were allowed to recover for 48 hours before subsequent treatment.
Protein Extraction and Western Blot Analysis
For western blot analysis, HCT116, U251, and MCF7 cells that had been grown in 100-mm dishes were incubated with CAN or inhibitors for the indicated times. Cells were then washed, harvested, and washed twice with ice-cold phosphate-buffered saline (PBS), and proteins were extracted in 100 µ L of ice-cold RIPA lysis buffer (50 mM Tris -HCl, pH 7.4, 150 mM NaCl, 1% NP40, 0.25% sodium deoxycholate, 1 mM PMSF, with 1 × complete mini protease inhibitor [Boehringer, Mannheim, Germany]). Extracts were kept on ice for 15 minutes and centrifuged at 10 000 × g for 15 minutes at 4°C, and the supernatants containing the clarified protein extracts were stored at Ϫ 80°C. Thawed protein extracts were subjected to electrophoresis on 4% -20% sodium dodecyl sulfate -polyacrylamide gels (80 µ g protein per lane). Proteins were then electroblotted onto PVDF membranes (Invitrogen), which were incubated with any of the following primary antibodies: mouse monoclonal antibody to HIF-1 ␣ (1:250 dilution, BD Biosciences, Franklin Lakes, NJ), rabbit polyclonal antibody to caspase 12 (1:1000, BD Biosciences); rabbit polyclonal antibodies to caspase 3, poly (ADP-ribose) polymerase (PARP), phospho-eEF2 (Thr56), total eEF2, phospho-eEF2k (Ser366), total eEF2k, total eIF4E, phospho-4E-BP1 (Thr37/46), total 4E-BP1, phospho-eIF-2 ␣ (Ser51), total eIF2 ␣ , phospho-JNK (Thr183/Tyr185), total JNK, phospho-p38 mitogen-activated protein kinase (MAPK) (Thr180/Tyr182), total p38 MAPK, and phospho-PKR (Thr451) (all used 1:1000, Cell Signaling Technology, Beverly, MA); rabbit polyclonal antibodies to PERK, ATF4, or GADD153/CHOP, or mouse monoclonal antibody to PKR (all used 1:500, Santa Cruz Biotechnology, Santa Cruz, CA); or mouse monoclonal antibody to actin (1:1000, ICN Biomedicals, Irvine, CA). Anti-mouse immunoglobulin G (IgG)-horseradish peroxidase (HRP) -conjugated, anti-goat IgG-HRP -conjugated, or anti-rabbit IgG-HRP -conjugated antibodies were used as secondary antibodies at 1:10 000 dilution. Antibody binding was visualized by enhanced chemiluminescence according to manufacturer's specification and recorded on autoradiography film (Amersham Biosciences, Freiburg, Germany).
Flow Cytometric Analysis of Apoptosis and Cell Cycle
Apoptosis was assayed by staining cells with the annexin Vfluorescein isothiocyanate (FITC) apoptosis kit (BD Bioscience) according to the manufacturer's instructions. Cells double-stained for both annexin V and PI were analyzed by flow cytometry using a FACScan (Becton Dickinson GmbH, Heidelberg, Germany). PI was used in conjunction with annexin V -FITC to distinguish cells in the earlier stages of apoptosis (annexin V-FITC positive, PI negative) from those in later stages of apoptosis or that were already dead (annexin V -FITC positive, PI positive). (Gated cells were plotted on a dot-plot showing annexin V staining and PI staining.) To measure the percentage of apoptotic cells, cells floating in the culture supernatants were collected by centrifugation and pooled with adherent cells recovered from the plates, fixed in cold 70% ethanol, and stained with PI (0.5 mg/mL in PBS). Cell cycle analysis was performed as previously described ( 25 ) . Caspase 12 activation was assessed using a fluorescent substrate kit (Biovision). The assay is based on detection of cleavage of the substrate ATAD-AFC (ATAD: acetyl-alanine-threoninealanine-aspartic acid; AFC: 7-amino-4-trifluoromethyl coumarin). Briefly, U251 cells that had been grown in 100-mm dishes and were incubated with CAN or inhibitors for the indicated times were washed, harvested, and washed twice more with icecold PBS. Then, 10 5 cells were incubated in a test tube with 5 µ L of ATAD-AFC substrate in PBS for 1 hour at 37°C and 5% CO 2 , then washed again with PBS, and immediately analyzed by flow cytometry. Samples were gated using forward scatter and side scatter to exclude cell debris not within normal cell size using CellQuest software (BD Biosciences).
Analysis of Protein Synthesis
U251 cells that had been grown in 100-mm dishes and were then incubated with CAN or inhibitors for the indicated times were labeled with a mixture of [ ] incorporation was measured by trichloroacetic acid (TCA) precipitation. In brief, equal amounts of cell lysates were added to 0.5 mL of 0.1 mg/mL bovine serum albumin containing 0.02% sodium azide and placed on ice. Ice-cold 20% TCA (0.5 mL) was added, and the mixture was vortexed vigorously and incubated for 30 minutes on ice. The samples were washed twice with 1 mL of ice-cold 10% TCA and twice with 1 mL of 100% ethanol. The pellets were solubilized in 1 mL of 1 M Tris -HCl, pH 8.0, and boiled for 5 minutes, and the radioactivity was measured in a scintillation counter (Packard Instrument Co., Meriden, CT). Results were normalized as the percent increase or decrease of [ 
Statistical Analysis
Differences in survival, apoptosis, caspase 12 activation, and inhibition of protein synthesis between groups were analyzed with a twosided unpaired Student t test by use of GraphPad Prism 3.00 (GraphPad Software, San Diego, CA). Results were considered to be statistically significant if P < .05. Experiments were usually replicated three times unless otherwise indicated. Protein synthesis data represent values derived from triplicate samples and are shown as means with 95% confidence intervals (CIs).
Results
CAN-Mediated Inhibition of Protein Synthesis
To determine whether CAN inhibits overall protein translation in cancer cells, we first measured its effects on de novo protein synthesis in U251 glioma cells. U251 cells were treated with 10 or 50 nM ( ]-Met/Cys label into TCAprecipitable protein was measured to reflect the relative level of protein translation. Cyclohexamide (40 µ g/ml), a known inhibitor of protein synthesis, was used as a positive control and inhibited protein synthesis by 88.2% (95% CI = 86.1% to 90.4%) compared with that in untreated control cells at 2 hours. Protein synthesis was decreased by 35.2% (95% CI = 33.3% to 37.3%) and 67.5% (95% CI = 62.3% to 72.6%) at 6 hours and 18 hours, respectively, in U251 cells treated with 10 nM CAN. By contrast, protein synthesis was inhibited by 58.7% (95% CI = 50.4% to 67.1%) and 89.5% (95% CI = 85.7% to 93.3%) at 4 hours and 18 hours, respectively, in U251 cells treated with 50 nM CAN compared with untreated controls. Thus, CAN inhibited protein synthesis in a dose-and time-dependent fashion in U251 cells.
We next assessed whether inhibition of protein synthesis by CAN was reversible. U251 cells were treated with 10 or 50 nM CAN for 6 hours, washed with PBS, and incubated in fresh culture media without CAN for an additional 16 hours before lysis. One hour before harvesting cell lysates, [ 35 S]-Met/Cys was added to the media and then TCA-precipitable counts were measured from lysates. As shown in Figure 1 , B , CAN-induced inhibition of protein translation was almost completely reversed by a 16-hour wash-out when the lower (10 nM), but not the higher (50 nM), concentration was used. Consistent with this result, we also found that CAN-mediated inhibition of hypoxia-induced HIF-1 ␣ protein expression was reversible in a dose-dependent fashion. As shown in Figure 1 , C , a 6-hour treatment of hypoxic U251 cells with CAN inhibited HIF-1 ␣ expression, particularly at doses of CAN more than 10 nM. The inhibition was reversible by a 16-hour wash-out in cells treated with up to 25 nM CAN but not in cells treated with 50 nM CAN, indicating a clear difference between the impact of low vs high doses of CAN in terms of inhibition of protein translation.
CAN-Mediated Induction of Apoptosis in Human Cancer Cells
Next, we investigated whether CAN inhibition of protein translation might be associated with induction of programmed cell death in cancer cells. U251 glioma cells were treated with CAN for 6 hours at concentrations of up to 100 nM, and cell survival and apoptosis were assessed by clonogenic assay ( Figure 2 Finally, U251 cells were treated in the absence or presence of increasing concentrations of CAN for 24 hours, at which point the cell cycle distribution was analyzed ( Supplementary Figure 4 , available online). A dose-dependent increase of the sub-G1 peak, consistent with apoptosis, was observed in U251 cells treated with increasing concentrations of CAN. In addition, U251 cells accumulated in S phase with a concomitant decrease of cells in G 0 /G 1 ( Supplementary Figure 4 , available online). We conclude that CAN induced dose-dependent apoptotic cell death in U251 and HCT116 cancer cells.
Mechanism of CAN-Induced Apoptosis: Caspase 12
To further characterize the signaling pathway(s) that are involved in CAN-induced apoptosis, U251 and HCT116 cells were treated for 24 hours in the absence or presence of increasing concentrations of CAN, and cleavage of the caspase substrate PARP was analyzed. CAN treatment resulted in the processing of full-length PARP (110 kD) to its 84 kD cleaved form in both HCT116 and U251 cells ( Figure 3, A ) , suggesting that CAN activates a caspase-dependent apoptotic program. Next, we used specific caspase inhibitors to identify the caspases involved in the induction of apoptosis by CAN. HCT116 cells were treated with 50 nM CAN for 48 hours in the absence or presence of a pan-caspase inhibitor or inhibitors of caspases 3, 8, 9, or 12 before annexin V staining and flow cytometry. were cultured for 6 hours in the absence of CAN under normoxic conditions or in the presence of the increasing concentrations of CAN under hypoxic conditions. Alternatively, cells were treated with CAN for 6 hours and then washed and incubated for additional 16 hours in the absence of CAN. Western blots were performed on total cell lysates using an anti-HIF-1 ␣ -specifi c antibody or an antibody to ␤ -actin (as a loading control).
annexin V -positive cells ( Figure 3, B ) . The addition of inhibitors of caspase 8 (Ac-ZIETD-fmk) or caspase 9 (Ac-ZLEHD-fmk) had little if any effect on the induction of apoptosis by CAN. By contrast, the caspase 12 inhibitor Ac-ZATAD-fmk and to a lesser extent the caspase 3 inhibitor Ac-DEVD-fmk substantially inhibited CANinduced apoptosis, resulting in 19% and 26% annexin V -positive cells, respectively. These results indicate that CAN induced apoptosis in HCT116 and U251 cells by a caspase 12 -dependent pathway and, at least in part, by a caspase 3 -dependent pathway.
Caspase 12 has been implicated in ER stress -dependent apoptosis, although its role in the induction of programmed cell death in human cells is still controversial ( 26 ) . To further probe the potential involvement of caspase 12 in the induction of apoptosis by CAN, U251 and HCT116 cells were treated for 24 hours with 0 -50 nM CAN before electrophoresis of cell lysates and immunoblotting. Blots were probed with specifi c antibodies that recognize procaspase 12, which is cleaved when it is activated, or that recognize caspase 3 fragments. As shown in Figure 3 , C , CAN induced a substantial reduction in levels of the uncleaved procaspase 12 protein, consistent with its dose-dependent cleavage and activation. Concomitant with the decrease in procaspase 12 levels, the levels of 17 -19 kD caspase 3 fragments increased, consistent with the activation of this effector caspase. In addition, functional activation of caspase 12 was assessed in U251 cells by measuring the conversion of a cell-permeable substrate, ATAD-AFC, which indicates activation of caspase 12. U251 cells, with or without CAN, were incubated in the presence of ATAD-AFC for 1 hour at 37°C, at which point fl uorescence, indicating cleavage of the substrate, was analyzed by fl ow cytometry. A substantial increase in fl uorescence was observed in cells treated with CAN for 24 hours ( Figure 3, D ) , similar to that in cells treated with thapsigargin and tunicamycin, which are known caspase 12 activators. In contrast, treatment of U251 cells with camptothecin, a topoisomerase I inhibitor, did not result in caspase 12 activation ( Figure 3, D ) . These results demonstrate that CAN induces apoptosis in at least two human cancer cell lines by a caspase-dependent pathway that apparently involves caspase 12 and caspase 3.
Mechanism of CAN-Induced Activities: Activation of p38 and JNK?
Inhibition of protein synthesis by other members of the tedanolide macrolide family, including 13-DT, has been associated with the activation of a ribotoxic stress response, a stress response that is induced by toxic substances and stimulates intracellular signaling pathways ( 27 ). 13-DT, which is at least 10-fold more potent than CAN in cytotoxicity assays ( 7 ), induces rapid phosphorylation of the stressactivated protein kinase/JNK and p38 MAPKs, two major down stream mediators of the ribotoxic stress response in NIH3T3 cells ( 7 ) . To investigate whether CAN also induces phosphorylation of the p38 and JNK stress-activated kinases, U251 cells were incubated with 10 nM 13-DT or 100 nM CAN, and p38 and JNK phosphorylation were measured by western blot analysis ( Figure 4, A ) . 13-DT induced rapid and transient phosphorylation of p38 and JNK, which occurred as early as 15 minutes after treatment and then substantially decreased by 60 minutes. In contrast, CAN induced a modest and transient phosphorylation of p38 and JNK that was observed after 30 minutes but was no longer detectable after 60 minutes. This pattern suggests that activation of p38 and JNK kinases may be involved in the early sensing of cellular stress but is unlikely to account for the sustained effects of CAN (eg, induction of apoptosis).
To test whether activation of p38 and JNK is required for the induction of apoptosis by CAN, U251 cells were treated with 100 nM CAN or 10 nM 13-DT for 24 hours in the absence or presence of pharmacological inhibitors of the activation of p38 (SB202190) and JNK (SP600125). Under these conditions, both SB202190 and SP600125 selectively inhibited activation of the corresponding target kinase by hydrogen peroxide, a known activator of stress kinases (data not shown). As illustrated in Figure 4 , B , treatment of U251 cells with SB202190 or SP600125 alone did not affect the percentage of cells that appeared to be apoptotic relative to the untreated control (less than 7% in either case).
Interestingly, induction of apoptosis by CAN (approximately 31% annexin V -positive cells) or 13-DT (approximately 28%
annexin V -positive cells) was not affected by pretreatment of the cells with either inhibitor, suggesting that activation of p38 and JNK is not required for induction of cell death by CAN and 13-DT.
CAN-Induced Phosphorylation of eIF2 ␣
To better understand the mechanism by which CAN inhibited protein translation, U251 cells were treated with increasing concentrations of CAN and the levels of expression and/or phosphorylation of Figure 4 . Induction of p38 and jun NH 2 -terminal kinase (JNK) phosphorylation by candidaspongiolide (CAN). A ) Time course of p38 and JNK phosphorylation. U251 cells were cultured in the absence or presence of 100 nM CAN or 10 nM 13-deoxytedanolide (13-DT) for 0 -60 minutes. Levels of phospho-p38 (Thr180/Tyr182), phospho-JNK (Thr183/Tyr185), total p38, and total JNK proteins were then assessed by western blot analysis. ␤ -Actin levels are shown as a loading control. B ) Apoptosis assays with p38 and JNK inhibitors. U251 cells were treated with 100 nM CAN or 10 nM 13-DT for 24 hours or left untreated and were cultured in the absence or presence of SB202190, a pharmacological inhibitor of p38 activation, or SP600125, an inhibitor of JNK activation. Apoptosis was assessed by fl ow cytometry after annexin V and propidium iodide staining. Percentages of annexin V -positive cells are indicated.
downstream targets of mTOR activity, which regulate cap-dependent protein translation, were analyzed. As shown in Figure 5 , A , one such target, 4EBP1, was phosphorylated in untreated U251 cells, presumably because of a loss of function of the PTEN tumor suppressor gene present in these cells ( 28 ) . No changes in either phosphorylation or expression of 4EBP1 were observed in U251 cells treated with 10 or 50 nM CAN. In addition, no changes in the total levels of eIF4E, another downstream target of mTOR, were observed. These results suggest that the effects of CAN on protein synthesis did not involve inhibition of the 4EBP1 -eIF4E pathway.
We then tested the levels of expression and phosphorylation of other factors known to be involved in translation initiation and elongation. eIF2 is an important regulatory protein for mRNA translation, and phosphorylation of the ␣ subunit of eIF2 is a welldocumented mechanism for inhibition of protein synthesis ( 12 ) . CAN induced eIF2 ␣ phosphorylation at Ser51 in a dosedependent manner ( Figure 5, A ) . In addition, CAN induced a marked increase in the phosphorylation of the protein elongation factor eEF2 at Thr56 ( Figure 5, A ) , a phosphorylation site associated with inhibition of its activity ( 15 ) . Phosphorylation of eEF2 at Thr56 was both time and dose dependent ( Supplementary Figure 5 , available online).
We further investigated the kinetics of eIF2 ␣ phosphorylation induced by CAN. U251 cells were exposed to 10 or 50 nM CAN for 2 -48 hours, and the phosphorylation of eIF2 ␣ was monitored by western blotting. At 10 nM, CAN induced eIF2 ␣ phosphorylation that was detectable at 6 hours, more pronounced at 16 hours, and persisted until at least 48 hours ( Figure 5, B ) . At 50 nM, CAN induced much greater phosphorylation of eIF2 ␣ , which was clearly detectable by 4 to 6 hours and was maintained up to at least 48 hours ( Figure 5, B ) . CAN at 10 and 50 nM also induced substantial phosphorylation of eIF2 ␣ in HCT116 cells ( Figure 5, C ) .
Taken together, our results demonstrate that CAN induced sustained phosphorylation of eIF2 ␣ in U251 and HCT116 cells. They also suggest that phosphorylation and inactivation of eIF2 ␣ and eEF2 may be responsible for the inhibition of protein synthesis caused by CAN.
Mechanism of CAN-Induced eIF2 ␣ Phosphorylation: Classic ER Stress?
Phosphorylation of eIF2 ␣ is a key event that mediates inhibition of translation during the ER stress and the unfolded protein response (UPR) ( 20 , 21 , 24 , 29 ) . In addition, our finding that CAN induced caspase 12 -dependent apoptosis raised the possibility that CAN might induce a classic ER stress response. We therefore examined the effects of CAN on the expression of proteins that are modulated during ER stress, including the bZIP transcriptional activators ATF4 and CHOP ( 20 ) . Thapsigargin, an ER Ca 2+ -ATPase inhibitor that is known to induce ER stress and eIF2 ␣ phosphorylation, was used as positive control. Consistent with earlier reports ( 24 ) , thapsigargin induced eIF2 ␣ phosphorylation and ATF4 and CHOP expression in a dose-dependent fashion in U251 cells ( Figure 6, A ) . By contrast, CAN induced only eIF2 ␣ phosphorylation and did not affect the levels of ATF4 and CHOP, suggesting that distinct pathways may mediate the ER response and eIF2 ␣ phosphorylation induced by CAN.
PERK is part of a signaling pathway that phosphorylates and inhibits eIF2 ␣ in response to stimuli that induce ER stress, such as glucose deprivation, severe hypoxia, and thapsigargin treatment. In the presence of ER stress conditions, misfolded proteins accumulate in the ER and activate distinct signalling pathways that mediate survival and/or cell death ( 20 , 21 , 29 ) . To investigate whether PERK is required for the phosphorylation of eIF2 ␣ induced by CAN, U251 cells were transfected with a siRNA targeting PERK (siPERK) or a scrambled negative control RNA (siNC), and cells were tested for eIF2 ␣ phosphorylation in response to CAN or thapsigargin 48 hours after transfection. As demonstrated in Figure 6 , B , transfection of U251 cells with siRNA directed against PERK almost completely abrogated PERK expression relative to cells transfected with control scrambled siRNA. CAN was equally able to induce eIF2 ␣ phosphorylation in U251 cells transfected with either siNC or siPERK, demonstrating that CAN induction of eIF2 ␣ phosphorylation is PERK independent. By contrast, thapsigargin, which is known to Figure 5 . Candidaspongiolide (CAN) induction of the phosphorylation of eukaryotic initiation factor-2 (eIF2)-␣ and eukaryotic elongation factor-2 (eEF2) in U251 and HCT116 cells. A ) Phosphorylation of translation regulatory proteins. U251 cells were treated with the indicated concentration of CAN for 16 hours. Levels of phospho-4EBP1 (Thr37/46), total 4EBP1, total eIF4E, phospho-eIF2 ␣ (Ser51), total eIF2 ␣ , phospho-eEF2 (Thr56), and total eEF2 were analyzed by western blot analysis. Levels of ␤ -actin are shown as loading control. B ) Time course of eIF2 ␣ inactivation. U251 cells were treated with 10 nM (upper panel) or 50 nM (lower panel) of CAN for the indicated times (ranging from 2 to 48 hours), and levels of total and phosphorylated eIF2 ␣ were analyzed by western blot analysis. C ) eIF2 ␣ phosphorylation in HCT116 cells. HCT116 cells were treated with increasing concentrations of CAN for 16 hours, and levels of total and phosphorylated eIF2 ␣ were analyzed by western blot analysis.
induce the UPR pathway, induced eIF2 ␣ phosphorylation in the presence but not the absence of PERK. These results suggest that CAN induced eIF2 ␣ phosphorylation by a biochemical pathway that is distinct from the UPR.
Requirement of eIF2 ␣ Phosphorylation for CAN-Mediated Induction of Apoptosis
To further investigate the role of eIF2 ␣ in the inhibition of protein synthesis and the induction of apoptosis by CAN, we generated U251 cells expressing a mutant allele of eIF2 ␣ that encodes a protein with a single amino acid substitution at position 51 (S51A). This mutated form of eIF2 ␣ acts as a dominant-negative protein to prevent the phosphorylation of wild-type eIF2 ␣ ( 24 ). As shown in Figure 7 , A , CAN induced eIF2 ␣ phosphorylation in U251-neo cells, that is, cells transfected with an empty vector containing the neomycin resistance gene. In contrast, both basal and CANinduced levels of eIF2 ␣ phosphorylation were dramatically reduced in cells that expressed the mutated form of eIF2 ␣ (U251-S51A).
To test the involvement of eIF2 ␣ in the inhibition of protein synthesis by CAN, we measured [ ( Figure 7, B ) . The presence of S51A-mutated eIF2 ␣ only partially abrogated the inhibition of protein synthesis by 10 or 50 nM CAN in U251-S/A cells, with a 71.2% (95% CI = 63.8% to 78.8%) decrease in [ 35 S]-Met/Cys incorporation still detectable in cells treated with CAN at 50 nM, despite the lack of eIF2 ␣ phosphorylation. These results suggest that eIF2 ␣ phosphorylation contributed to, but was not suffi cient for, the inhibition of protein synthesis observed in cells treated with CAN and are consistent with the possibility that other factors, for example, eEF2 phosphorylation, may be involved. They also confi rmed our earlier fi nding that low and high doses of CAN may have distinct impacts on inhibition of protein synthesis.
We next addressed the role of eIF2 ␣ phosphorylation in the induction of apoptosis by CAN. Apoptosis was measured by the annexin V assay in U251-neo and U251-S51A cells treated with varying amounts of CAN for 24 hours ( Figure 7, C ) . As in previous experiments, CAN induced apoptosis in a dose-dependent fashion in U251-neo cells. In contrast, apoptosis was substantially decreased in U251-S51A cells ( Figure 7, C ) . Indeed, CAN induced 21% and 33% of the U251-neo cells to undergo programmed cell death at 10 and 50 nM concentrations, respectively. In contrast, it induced only 8% and 14% of the U251-S51A cells to undergo programmed cell death at 10 and 50 nM concentrations, respectively ( Figure 7 , C ). Camptothecin, a DNA damaging agent that causes programmed cell death by a topoisomerase I -dependent mechanism, induced similar levels of apoptosis in both U251-neo and U251-S51A cells (data not shown).
Taken together, these results demonstrate that phosphorylation of eIF2 ␣ was required for the induction of apoptosis by CAN, but not by a classic DNA damaging agent. In addition, they suggest that eIF2 ␣ phosphorylation was essential for the induction of apoptosis by CAN but was only a contributing factor for the inhibition of protein synthesis.
Mechanism of CAN-Induced eIF2 ␣ Phosphorylation: PKR
We next sought to determine which kinase(s) mediate phosphorylation of eIF2 ␣ induced by CAN. eIF2 ␣ can be phosphorylated by a number of kinases, including PERK, PKR, HRI, and GCN2, which are activated during distinct stress conditions ( 14 , 24 , 30 -33 ) . Because eIF2 ␣ phosphorylation has been implicated in the induction of apoptosis in response to PKR activation or overexpression ( 34 -37 ), we determined whether CAN increased the levels of the active, phosphorylated form of PKR, again using a phosphospecific antibody on western blots. As shown in Figure 8 , A , CAN induced a dose-dependent increase in PKR phosphorylation without affecting the total levels of PKR. Notably, pretreatment of U251 cells with 2-AP, an inhibitor of PKR, completely abrogated CAN-induced eIF2 ␣ phosphorylation in U251 cells ( Figure 8, B ) . The involvement of PKR in the induction of eIF2 ␣ phosphorylation by CAN was further supported by experiments using siRNA targeting PKR. As shown in Figure 8 , C , PKR levels were substantially reduced in cells transfected with PKRspecific siRNA (siPKR) relative to cells transfected with a negative control siRNA (siNC). More importantly, the induction of eIF2 ␣ phosphorylation induced by CAN in U251 cells Figure 6 . Effect of candidaspongiolide (CAN) on classic endoplasmic reticulum stress response pathways. A ) Effects of CAN on unfolded protein response pathway components. U251 cells were treated with the indicated concentrations of CAN or thapsigargin (Thaps) for 16 and 4 hours, respectively. Cells were then lysed, and levels of total and phosphorylated (pSer51) eukaryotic initiation factor-2 (eIF2)-␣ , total ATF4, and GADD153/ CHOP were assayed by western blot analysis. ␤ -Actin is shown as a loading control. B ) Effect of reduced levels of PERK on eIF2 ␣ phosphorylation. U251 cells were transiently transfected with negative control smallinterfering RNA (siNC) or siRNA targeting PERK (siPERK). After 48 hours, cells were treated with the indicated concentrations of CAN or thapsigargin for 16 and 4 hours, respectively, and levels of PERK, phosphoeIF2 ␣ (Ser51), and total eIF2 ␣ were assayed by western blotting. ␤ -actin levels are shown as loading control.
transfected with siNC was not detectable in cells transfected with siPKR, further demonstrating an essential role for PKR in the induction of eIF2 ␣ phosphorylation by CAN ( Figure 8, C ) .
The results shown in Figure 7 , C had indicated that eIF2 ␣ is essential for the induction of apoptosis by CAN. Therefore, we reasoned that the inhibition of PKR activation might not only be required for eIF2 ␣ phosphorylation by CAN but also affect the ability of CAN to induce apoptosis. To address this question, U251 cells were treated with increasing concentrations of CAN in the absence or presence of 5 mM 2-AP. As shown in Figure 8 , D, 5 mM 2-AP caused a slight increase in apoptosis relative to levels in untreated cells (12% vs 7%). However, addition of 2-AP substantially decreased the amount of apoptosis induced by 50 nM CAN, and the percentage of apoptotic cells induced by treatment with 50 nM CAN dropped from 33% in the absence of 2-AP to 15% in the presence of 2-AP. The fi nding further supports the involvement of the PKR kinase in the signal transduction pathways induced by CAN ( Figure 8, D ) .
Differences in CAN-Mediated Activities in Normal Cells vs Cancer Cells
Our original hypothesis that led us to further investigate the mechanism of action of CAN was that cancer cells might be more sensitive to inhibitors of protein synthesis than normal cells. To further test this hypothesis, we investigated the effects of CAN on protein synthesis and apoptosis in normal human fibroblasts. We first tested the effects of CAN on eIF2 ␣ phosphorylation in two normal human fi broblast cell lines, AG06858 and AG068103. Both normal human fi broblast cell lines showed constitutive phosphorylation of eIF2 ␣ that was not substantially increased by treatment with up to 100 nM CAN ( Figure 9, A ) . though CAN inhibits protein synthesis in normal human fi broblasts, these cells are much less sensitive than cancer cell lines to eIF2 ␣ phosphorylation and apoptosis induced by CAN.
Discussion
Natural products are an important source of novel, complex chemicals, many of which exhibit potent cytotoxic activities and are currently being used for cancer therapy. In this study we have examined the mechanism of action of CAN, a novel natural product isolated from the marine sponge Candidaspongia sp.
We observed two main effects in cells treated with CAN: inhibition of protein synthesis and induction of apoptosis. Also, we have provided evidence that the main signaling pathway required for the induction of cell death by CAN is the PKR-dependent phosphorylation of eIF2 ␣ and not a pathway downstream of inhibition of protein synthesis. We demonstrated that 1) in cells stably transfected with a dominant-negative allele of eIF2 ␣ , CAN no longer caused eIF2 ␣ phosphorylation and induction of apoptosis was substantially impaired, yet protein synthesis was effectively inhibited; 2) inhibition of PKR by siRNA or 2-AP prevented phosphorylation of eIF2 ␣ and induction of apoptosis by CAN; 3) CAN effi ciently inhibited protein synthesis in normal human fi broblasts, yet did not induce phosphorylation of eIF2 ␣ or apoptosis even at high concentrations; and 4) activation of p38 and JNK was transient and not required for the induction of cell death by CAN. These results are consistent with at least two possibilities. The fi rst possibility is that CAN retains some activities of other members of the tedanolide family of macrolides, such as induction of stress-activated kinases JNK/p38 and inhibition of protein synthesis, yet has a unique propensity to induce phosphorylation of eIF2 ␣ and apoptosis. The second possibility is that inhibition of protein synthesis, although possibly contributing to the overall cytotoxic activity of CAN, is necessary but not suffi cient to trigger an apoptotic cascade.
Recently, the discovery of inhibitors of protein translation has attracted considerable interest for their potential use in cancer therapy, and high-throughput screens have been successfully implemented to identify small-molecule modulators of translation initiation ( 38 -41 ) . Selective inhibition of protein translation by most of these agents has been attributed to their binding to the structured conformation of the 5 ′ untranslated region (5 ′ -UTR) of mRNAs. Indeed, it has been postulated that mRNAs that have a short unstructured 5 ′ -UTR, for example, ␤ -actin, would be less sensitive to inhibitors of translation initiation than those mRNAs with long, highly structured 5 ′ -UTRs, for example, those of oncogenes ( 41 ) . However, it is also conceivable that global protein synthesis inhibition may preferentially affect short-lived proteins, many of which are the products of mRNAs with long, highly structured 5 ′ -UTRs. Indeed, our results indicate that CAN predominantly inhibited proteins with a short half-life, for example, HIF-1 ␣ , whereas it had little effect on proteins with a long half-life, including HIF-1 ␤ , ␤ -actin, and all the kinases tested in this study, even after prolonged treatment at high concentration. Whether this result refl ects an intrinsic property of CAN to preferentially target short-lived proteins or is a consequence of the extent and duration of global inhibition of translation remains to be determined. Likewise, the extent to which modulation of translation may impact the therapeutic potential of CAN is not yet known.
The fi nding that CAN inhibited protein synthesis in normal human fi broblasts yet did not induce eIF2 ␣ phosphorylation and apoptosis is consistent with our conclusion that eIF2 ␣ phosphorylation induced by CAN is required for the induction of apoptosis, and it suggests that metabolically active cancer cells, in which key translational factors are frequently dysregulated, may be more sensitive than normal cells to inhibition of protein synthesis. Indeed, cancer cells readily adapt to stress conditions, including hypoxia and nutrient starvation, and are less responsive than normal cells to physiological control mechanisms that regulate protein synthesis ( 42 ) . Interestingly, normal human fi broblasts showed constitutive phosphorylation of eIF2 ␣ at Ser51 that was not affected by CAN. Similar results have been reported in MCF10A human breast epithelial cells, which, unlike breast cancer cell lines, express constitutive, but not inducible, eIF2 ␣ phosphorylation at Ser51, consistent with distinct regulation of eIF2 ␣ in normal and cancer cell lines ( 42 ) .
Inhibitory phosphorylation of eIF2 ␣ at serine 51 is observed under diverse stress conditions, including ER stress and the UPR ( 20 , 21 ) . Although CAN induced consistent and sustained eIF2 ␣ phosphorylation at serine 51, it did not activate ATF4, CHOP, or PERK, all of which are involved in the classic UPR. Several kinases have been implicated in the phosphorylation of eIF2 ␣ under distinct stress conditions. Our results clearly implicate PKR as the upstream kinase that is involved in CAN-dependent eIF2 ␣ phosphorylation and apoptosis. Indeed, inhibition of PKR, by either specifi c siRNA or 2-AP, completely abrogated eIF2 ␣ phosphorylation and apoptosis induced by CAN. PKR is a well-characterized kinase that is activated by viral double-stranded RNA (dsRNA) to phosphorylate eIF2 ␣ and inhibit protein synthesis. Activation of a PKR-dependent pathway has been associated with induction of apoptosis in response to different cellular stress conditions, including the presence of dsRNA, serum deprivation, and TNF ␣ treatment ( 22 , 35 , 37 , 43 , 44 ) .
CAN appeared to induce a unique cell death cascade involving activation of a caspase 12 -dependent apoptotic pathway. Caspase 12 is an initiator caspase that regulates ER stress -mediated apoptosis ( 26 ) . Thapsigargin, a specifi c inhibitor of the ER-associated Ca ++ ATPase, induces processing of caspase 12 and apoptotic cell death ( 26 ) . The role of caspase 12 in ER stress -induced apoptosis is well established in rodents ( 26 ) yet still debated in humans, although evidence of a human caspase 12 -like protein has been provided ( 45 -47 ) . Our fi ndings are consistent with the involvement of a human caspase 12 -like protein in the induction of apoptosis by CAN. Indeed, apoptotic cell death induced by CAN was almost completely abrogated by Z-ATAD, an inhibitor of caspase 12, or by Z-VAD, a global caspase inhibitor. By contrast, inhibitors of caspase 8 or caspase 9 had no effect on the induction of apoptosis by CAN, suggesting activation of a pathway distinct from the intrinsic and extrinsic apoptotic pathways. Involvement of caspase 12 was further suggested by dose-dependent cleavage of procaspase 12 by CAN and by induction of caspase 12 activity, as assessed by a fl uorescent enzymatic assay, to a similar extent as by thapsigargin or tunicamycin, inducers of ER stress. Overall, our results are consistent with the activation of an ER stress -like pathway by CAN, with induction of PKR-dependent phosphorylation of eIF2 ␣ and activation of a caspase 12 -dependent apoptotic pathway. Further studies will be required to fully elucidate the triggering signals leading to activation of caspase 12 and its association with eIF2 ␣ phosphorylation.
CAN is a novel compound with potential antitumor activity. Members of the tedanolide family of compounds exert potent cytotoxic activity, which is associated with inhibition of protein synthesis. Agents affecting global metabolic pathways, such as protein translation, face intense scrutiny for clinical development. However, recent successful examples of anticancer agents that affect protein degradation (proteasome inhibitors), chaperone function (Hsp90), mRNA synthesis (fl avopiridol), or protein acetylation (HDAC) have lessened the skepticism surrounding these types of compounds. Potential for further development of CAN as an anticancer agent will ultimately be determined by availability of this compound, either from the primary source or through synthetic chemistry, and the magnitude of its "therapeutic window."
Thus far, our work is limited by the fact we have demonstrated the propensity of CAN to kill cancer cells more readily than normal cells only through in vitro experiments in cell lines. The evidence provided by this study, which also identifi es a biomarker, eIF2 ␣ phosphorylation, that is associated with induction of cell death by CAN, may form the basis for further preclinical studies to test the effi cacy and safety of this drug on mouse tumor models and may facilitate the assessment of its potential for therapeutic applications in humans.
